Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas Hongsai ChenHe HuangHao Wu Laboratory Investigation 02 May 2019 Pages: 369 - 379
Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis Lindsey LowderJennifer HauensteinSoma Sengupta Laboratory Investigation Open access 09 May 2019 Pages: 381 - 392
Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres Kavneet KaurPrerana JhaChitra Sarkar Laboratory Investigation 18 May 2019 Pages: 393 - 403
Fucosyltransferase 4 and 7 mediates adhesion of non-small cell lung cancer cells to brain-derived endothelial cells and results in modification of the blood–brain-barrier: in vitro investigation of CD15 and CD15s in lung-to-brain metastasis Samah A. JassamZaynah MaherallyHelen L. Fillmore Laboratory Investigation Open access 18 May 2019 Pages: 405 - 415
Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells Parvez VoraMathieu SeyfridSheila K. Singh Laboratory Investigation 21 May 2019 Pages: 417 - 428
Triptolide reverses helper T cell inhibition and down-regulates IFN-γ induced PD-L1 expression in glioma cell lines Lei ZhangJohn S. Yu Laboratory Investigation 31 May 2019 Pages: 429 - 436
Satellite lesions of DNET: implications for seizure and tumor control after resection Jeyul YangSeung-Ki KimJi Hoon Phi Clinical Study 03 May 2019 Pages: 437 - 445
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial Sara PedrettiLaura MasiniMichela Buglione Clinical Study 04 May 2019 Pages: 447 - 455
Spinal location is prognostic of survival for solitary-fibrous tumor/hemangiopericytoma of the central nervous system Deborah BoyettConnor J. KinslowTony J. C. Wang Clinical Study 03 May 2019 Pages: 457 - 464
Effect of patient age on glioblastoma perioperative treatment costs: a value driven outcome database analysis Brandon A. SherrodNicholas T. GamboaSarah T. Menacho Clinical Study 04 May 2019 Pages: 465 - 473
Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature Timothy K. NguyenJames PerryArjun Sahgal Clinical Study 03 May 2019 Pages: 475 - 481
Fronto-limbic white matter microstructure, behavior, and emotion regulation in survivors of pediatric brain tumor Ryan WierHolly A. AleksonisKristen R. Hoskinson Clinical Study 09 May 2019 Pages: 483 - 493
Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study Penghui YanRunzhi HuangZongqiang Huang Clinical Study 14 May 2019 Pages: 495 - 503
First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial Christopher J. FunesRyan A. MaceAna-Maria Vranceanu Clinical Study 02 May 2019 Pages: 505 - 513
Contrast-enhancement in supratentorial low-grade gliomas: a classic prognostic factor in the molecular age Florian CastetEnrique AlanyaJordi Bruna Clinical Study 03 May 2019 Pages: 515 - 523
LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells Guoxiong LiYingqian CaiJiansheng Chen Clinical Study 06 June 2019 Pages: 525 - 536
Health-related quality of life of patients with brain metastases selected for stereotactic radiosurgery Eline VerhaakKarin GehringMargriet M. Sitskoorn Clinical Study Open access 09 May 2019 Pages: 537 - 546
Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences Andrew YousefMartin J. RutkowskiTarik Tihan Clinical Study 14 May 2019 Pages: 547 - 552
Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer Youngsan KoHo-Shin GwakHeon Yoo Clinical Study 14 May 2019 Pages: 553 - 562
Comparative analysis of intracranial meningiomas in patients younger than 40 years Tianhao HuRun WangSheng Han Clinical Study 13 May 2019 Pages: 563 - 571
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) Kurt A. JaeckleS. K. AndersonEvanthia Galanis Clinical Study 22 May 2019 Pages: 573 - 581
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) Kurt A. JaeckleS. K. AndersonEvanthia Galanis Correction 05 June 2019 Pages: 583 - 583
The case for radiosurgery for brainstem metastases Evan WinogradCharlotte I. RiversDheerendra Prasad Clinical Study 24 May 2019 Pages: 585 - 595
Multisession radiosurgery for perioptic meningiomas: medium-to-long term results from a CyberKnife cooperative study Marcello MarchettiAlfredo ContiLaura Fariselli Clinical Study 22 May 2019 Pages: 597 - 604
Cost-effectiveness of tumor-treating fields added to maintenance temozolomide in patients with glioblastoma: an updated evaluation using a partitioned survival model Martin ConnockPeter AugusteXavier Armoiry Clinical Study 24 May 2019 Pages: 605 - 611
Applicability and limitations of a recently-proposed prognostic grading metric, initial brain metastasis velocity, for brain metastasis patients undergoing stereotactic radiosurgery Masaaki YamamotoHitoshi AiyamaBierta E. Barfod Clinical Study 28 May 2019 Pages: 613 - 621
